The variability in product preparation, lack of standardization, and placebo effects further cloud their clinical utility (Tschopp et al., 2023), (Paget et al., 2023)
Those with poorly controlled blood glucose, poorly controlled blood pressure, and/or those at a higher risk of major cardiovascular events such as heart attack or stroke are good candidates for this intervention as this drug has shown to help with all of these conditions in a very substantial way.7 While these GLP-1 agonists were being studied for efficacy in treating diabetes, researchers noticed that many participants were seeing the side effect of weight loss
Plant Cell 25:45804595
Who Should Choose Phentermine
Diabetologia (2019) 62(7):115466
weekly for semaglutide, dulaglutide, and tirzepatide) and following dose escalation schedules carefully can reduce the intensity of gastrointestinal side effects that contribute to taste changes